Global Evolocumab Market Research Report 2024

Report ID: 1893706 | Published Date: Sep 2024 | No. of Page: 117 | Base Year: 2023 | Rating: 4.1 | Webstory: Check our Web story
1 Evolocumab Market Overview
    1.1 Product Overview and Scope of Evolocumab
    1.2 Evolocumab Segment by Type
        1.2.1 Global Evolocumab Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Patent
        1.2.3 Generic
    1.3 Evolocumab Segment by Application
        1.3.1 Global Evolocumab Sales Comparison by Application: (2022-2028)
        1.3.2 Chemical
        1.3.3 Pharmaceutical
    1.4 Global Evolocumab Market Size Estimates and Forecasts
        1.4.1 Global Evolocumab Revenue 2017-2028
        1.4.2 Global Evolocumab Sales 2017-2028
        1.4.3 Evolocumab Market Size by Region: 2017 Versus 2021 Versus 2028
2 Evolocumab Market Competition by Manufacturers
    2.1 Global Evolocumab Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Evolocumab Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Evolocumab Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Evolocumab Manufacturing Sites, Area Served, Product Type
    2.5 Evolocumab Market Competitive Situation and Trends
        2.5.1 Evolocumab Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Evolocumab Players Market Share by Revenue
        2.5.3 Global Evolocumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Evolocumab Retrospective Market Scenario by Region
    3.1 Global Evolocumab Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Evolocumab Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Evolocumab Market Facts & Figures by Country
        3.3.1 North America Evolocumab Sales by Country
        3.3.2 North America Evolocumab Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe Evolocumab Market Facts & Figures by Country
        3.4.1 Europe Evolocumab Sales by Country
        3.4.2 Europe Evolocumab Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Evolocumab Market Facts & Figures by Region
        3.5.1 Asia Pacific Evolocumab Sales by Region
        3.5.2 Asia Pacific Evolocumab Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Evolocumab Market Facts & Figures by Country
        3.6.1 Latin America Evolocumab Sales by Country
        3.6.2 Latin America Evolocumab Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Evolocumab Market Facts & Figures by Country
        3.7.1 Middle East and Africa Evolocumab Sales by Country
        3.7.2 Middle East and Africa Evolocumab Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Evolocumab Historic Market Analysis by Type
    4.1 Global Evolocumab Sales Market Share by Type (2017-2022)
    4.2 Global Evolocumab Revenue Market Share by Type (2017-2022)
    4.3 Global Evolocumab Price by Type (2017-2022)
5 Global Evolocumab Historic Market Analysis by Application
    5.1 Global Evolocumab Sales Market Share by Application (2017-2022)
    5.2 Global Evolocumab Revenue Market Share by Application (2017-2022)
    5.3 Global Evolocumab Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 BOCSCI
        6.1.1 BOCSCI Corporation Information
        6.1.2 BOCSCI Description and Business Overview
        6.1.3 BOCSCI Evolocumab Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 BOCSCI Evolocumab Product Portfolio
        6.1.5 BOCSCI Recent Developments/Updates
    6.2 Carbosynth
        6.2.1 Carbosynth Corporation Information
        6.2.2 Carbosynth Description and Business Overview
        6.2.3 Carbosynth Evolocumab Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Carbosynth Evolocumab Product Portfolio
        6.2.5 Carbosynth Recent Developments/Updates
    6.3 TargetMol Chemicals
        6.3.1 TargetMol Chemicals Corporation Information
        6.3.2 TargetMol Chemicals Description and Business Overview
        6.3.3 TargetMol Chemicals Evolocumab Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 TargetMol Chemicals Evolocumab Product Portfolio
        6.3.5 TargetMol Chemicals Recent Developments/Updates
    6.4 Chemren Bio-Engineering
        6.4.1 Chemren Bio-Engineering Corporation Information
        6.4.2 Chemren Bio-Engineering Description and Business Overview
        6.4.3 Chemren Bio-Engineering Evolocumab Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Chemren Bio-Engineering Evolocumab Product Portfolio
        6.4.5 Chemren Bio-Engineering Recent Developments/Updates
    6.5 DC Chemicals
        6.5.1 DC Chemicals Corporation Information
        6.5.2 DC Chemicals Description and Business Overview
        6.5.3 DC Chemicals Evolocumab Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 DC Chemicals Evolocumab Product Portfolio
        6.5.5 DC Chemicals Recent Developments/Updates
    6.6 Hefei Enli Medical Technology
        6.6.1 Hefei Enli Medical Technology Corporation Information
        6.6.2 Hefei Enli Medical Technology Description and Business Overview
        6.6.3 Hefei Enli Medical Technology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Hefei Enli Medical Technology Evolocumab Product Portfolio
        6.6.5 Hefei Enli Medical Technology Recent Developments/Updates
    6.7 Hefei Hirisun Pharmatech
        6.6.1 Hefei Hirisun Pharmatech Corporation Information
        6.6.2 Hefei Hirisun Pharmatech Description and Business Overview
        6.6.3 Hefei Hirisun Pharmatech Evolocumab Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Hefei Hirisun Pharmatech Evolocumab Product Portfolio
        6.7.5 Hefei Hirisun Pharmatech Recent Developments/Updates
    6.8 Hubei Kele Fine Chemical
        6.8.1 Hubei Kele Fine Chemical Corporation Information
        6.8.2 Hubei Kele Fine Chemical Description and Business Overview
        6.8.3 Hubei Kele Fine Chemical Evolocumab Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Hubei Kele Fine Chemical Evolocumab Product Portfolio
        6.8.5 Hubei Kele Fine Chemical Recent Developments/Updates
    6.9 Hubei Xingcheng Biotechnology
        6.9.1 Hubei Xingcheng Biotechnology Corporation Information
        6.9.2 Hubei Xingcheng Biotechnology Description and Business Overview
        6.9.3 Hubei Xingcheng Biotechnology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Hubei Xingcheng Biotechnology Evolocumab Product Portfolio
        6.9.5 Hubei Xingcheng Biotechnology Recent Developments/Updates
    6.10 Hubei Zhongshan Medical Technology
        6.10.1 Hubei Zhongshan Medical Technology Corporation Information
        6.10.2 Hubei Zhongshan Medical Technology Description and Business Overview
        6.10.3 Hubei Zhongshan Medical Technology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Hubei Zhongshan Medical Technology Evolocumab Product Portfolio
        6.10.5 Hubei Zhongshan Medical Technology Recent Developments/Updates
    6.11 Nantong Feiyu Biological Technology
        6.11.1 Nantong Feiyu Biological Technology Corporation Information
        6.11.2 Nantong Feiyu Biological Technology Evolocumab Description and Business Overview
        6.11.3 Nantong Feiyu Biological Technology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Nantong Feiyu Biological Technology Evolocumab Product Portfolio
        6.11.5 Nantong Feiyu Biological Technology Recent Developments/Updates
    6.12 Nantong Hi-Future Biotechnology
        6.12.1 Nantong Hi-Future Biotechnology Corporation Information
        6.12.2 Nantong Hi-Future Biotechnology Evolocumab Description and Business Overview
        6.12.3 Nantong Hi-Future Biotechnology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 Nantong Hi-Future Biotechnology Evolocumab Product Portfolio
        6.12.5 Nantong Hi-Future Biotechnology Recent Developments/Updates
    6.13 Shanghai Biochempartner
        6.13.1 Shanghai Biochempartner Corporation Information
        6.13.2 Shanghai Biochempartner Evolocumab Description and Business Overview
        6.13.3 Shanghai Biochempartner Evolocumab Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 Shanghai Biochempartner Evolocumab Product Portfolio
        6.13.5 Shanghai Biochempartner Recent Developments/Updates
    6.14 Shanghai Loulan Biotechnology
        6.14.1 Shanghai Loulan Biotechnology Corporation Information
        6.14.2 Shanghai Loulan Biotechnology Evolocumab Description and Business Overview
        6.14.3 Shanghai Loulan Biotechnology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
        6.14.4 Shanghai Loulan Biotechnology Evolocumab Product Portfolio
        6.14.5 Shanghai Loulan Biotechnology Recent Developments/Updates
    6.15 Shanghai Macklin Biochemical
        6.15.1 Shanghai Macklin Biochemical Corporation Information
        6.15.2 Shanghai Macklin Biochemical Evolocumab Description and Business Overview
        6.15.3 Shanghai Macklin Biochemical Evolocumab Sales, Revenue and Gross Margin (2017-2022)
        6.15.4 Shanghai Macklin Biochemical Evolocumab Product Portfolio
        6.15.5 Shanghai Macklin Biochemical Recent Developments/Updates
    6.16 Shanghai Minkai Biotechnology
        6.16.1 Shanghai Minkai Biotechnology Corporation Information
        6.16.2 Shanghai Minkai Biotechnology Evolocumab Description and Business Overview
        6.16.3 Shanghai Minkai Biotechnology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
        6.16.4 Shanghai Minkai Biotechnology Evolocumab Product Portfolio
        6.16.5 Shanghai Minkai Biotechnology Recent Developments/Updates
    6.17 Shanghai Ruihui Chemical Technology
        6.17.1 Shanghai Ruihui Chemical Technology Corporation Information
        6.17.2 Shanghai Ruihui Chemical Technology Evolocumab Description and Business Overview
        6.17.3 Shanghai Ruihui Chemical Technology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
        6.17.4 Shanghai Ruihui Chemical Technology Evolocumab Product Portfolio
        6.17.5 Shanghai Ruihui Chemical Technology Recent Developments/Updates
    6.18 Shanghai Yifei Biotechnology
        6.18.1 Shanghai Yifei Biotechnology Corporation Information
        6.18.2 Shanghai Yifei Biotechnology Evolocumab Description and Business Overview
        6.18.3 Shanghai Yifei Biotechnology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
        6.18.4 Shanghai Yifei Biotechnology Evolocumab Product Portfolio
        6.18.5 Shanghai Yifei Biotechnology Recent Developments/Updates
    6.19 Sichuan Weiqi Biotechnology
        6.19.1 Sichuan Weiqi Biotechnology Corporation Information
        6.19.2 Sichuan Weiqi Biotechnology Evolocumab Description and Business Overview
        6.19.3 Sichuan Weiqi Biotechnology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
        6.19.4 Sichuan Weiqi Biotechnology Evolocumab Product Portfolio
        6.19.5 Sichuan Weiqi Biotechnology Recent Developments/Updates
    6.20 Taizhou KEDE Chemical
        6.20.1 Taizhou KEDE Chemical Corporation Information
        6.20.2 Taizhou KEDE Chemical Evolocumab Description and Business Overview
        6.20.3 Taizhou KEDE Chemical Evolocumab Sales, Revenue and Gross Margin (2017-2022)
        6.20.4 Taizhou KEDE Chemical Evolocumab Product Portfolio
        6.20.5 Taizhou KEDE Chemical Recent Developments/Updates
    6.21 Taizhou Kerui Bio-Technology
        6.21.1 Taizhou Kerui Bio-Technology Corporation Information
        6.21.2 Taizhou Kerui Bio-Technology Evolocumab Description and Business Overview
        6.21.3 Taizhou Kerui Bio-Technology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
        6.21.4 Taizhou Kerui Bio-Technology Evolocumab Product Portfolio
        6.21.5 Taizhou Kerui Bio-Technology Recent Developments/Updates
    6.22 WeiShi Reagent
        6.22.1 WeiShi Reagent Corporation Information
        6.22.2 WeiShi Reagent Evolocumab Description and Business Overview
        6.22.3 WeiShi Reagent Evolocumab Sales, Revenue and Gross Margin (2017-2022)
        6.22.4 WeiShi Reagent Evolocumab Product Portfolio
        6.22.5 WeiShi Reagent Recent Developments/Updates
    6.23 Wuhan Fortuna Chemical
        6.23.1 Wuhan Fortuna Chemical Corporation Information
        6.23.2 Wuhan Fortuna Chemical Evolocumab Description and Business Overview
        6.23.3 Wuhan Fortuna Chemical Evolocumab Sales, Revenue and Gross Margin (2017-2022)
        6.23.4 Wuhan Fortuna Chemical Evolocumab Product Portfolio
        6.23.5 Wuhan Fortuna Chemical Recent Developments/Updates
    6.24 Wuhan Sunrise Technology Development
        6.24.1 Wuhan Sunrise Technology Development Corporation Information
        6.24.2 Wuhan Sunrise Technology Development Evolocumab Description and Business Overview
        6.24.3 Wuhan Sunrise Technology Development Evolocumab Sales, Revenue and Gross Margin (2017-2022)
        6.24.4 Wuhan Sunrise Technology Development Evolocumab Product Portfolio
        6.24.5 Wuhan Sunrise Technology Development Recent Developments/Updates
    6.25 Wuhan Weisman Bioengineering
        6.25.1 Wuhan Weisman Bioengineering Corporation Information
        6.25.2 Wuhan Weisman Bioengineering Evolocumab Description and Business Overview
        6.25.3 Wuhan Weisman Bioengineering Evolocumab Sales, Revenue and Gross Margin (2017-2022)
        6.25.4 Wuhan Weisman Bioengineering Evolocumab Product Portfolio
        6.25.5 Wuhan Weisman Bioengineering Recent Developments/Updates
    6.26 Wuhan Yingnuo Pharmaceutical Technology
        6.26.1 Wuhan Yingnuo Pharmaceutical Technology Corporation Information
        6.26.2 Wuhan Yingnuo Pharmaceutical Technology Evolocumab Description and Business Overview
        6.26.3 Wuhan Yingnuo Pharmaceutical Technology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
        6.26.4 Wuhan Yingnuo Pharmaceutical Technology Evolocumab Product Portfolio
        6.26.5 Wuhan Yingnuo Pharmaceutical Technology Recent Developments/Updates
7 Evolocumab Manufacturing Cost Analysis
    7.1 Evolocumab Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Evolocumab
    7.4 Evolocumab Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Evolocumab Distributors List
    8.3 Evolocumab Customers
9 Evolocumab Market Dynamics
    9.1 Evolocumab Industry Trends
    9.2 Evolocumab Market Drivers
    9.3 Evolocumab Market Challenges
    9.4 Evolocumab Market Restraints
10 Global Market Forecast
    10.1 Evolocumab Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Evolocumab by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Evolocumab by Type (2023-2028)
    10.2 Evolocumab Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Evolocumab by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Evolocumab by Application (2023-2028)
    10.3 Evolocumab Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Evolocumab by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Evolocumab by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer
List of Tables
    Table 1. Global Evolocumab Sales Growth Rate Comparison by Type (2022-2028) & (Kg) & (US$ Million)
    Table 2. Global Evolocumab Sales Growth Rate Comparison by Application (2022-2028) & (Kg) & (US$ Million)
    Table 3. Global Evolocumab Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Evolocumab Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Evolocumab Sales (Kg) of Key Manufacturers (2017-2022)
    Table 6. Global Evolocumab Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Evolocumab Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Evolocumab Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Evolocumab Average Price (US$/Kg) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Evolocumab Manufacturing Sites and Area Served
    Table 11. Manufacturers Evolocumab Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Evolocumab by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Evolocumab as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Evolocumab Sales by Region (2017-2022) & (Kg)
    Table 16. Global Evolocumab Sales Market Share by Region (2017-2022)
    Table 17. Global Evolocumab Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Evolocumab Revenue Market Share by Region (2017-2022)
    Table 19. North America Evolocumab Sales by Country (2017-2022) & (Kg)
    Table 20. North America Evolocumab Sales Market Share by Country (2017-2022)
    Table 21. North America Evolocumab Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Evolocumab Revenue Market Share by Country (2017-2022)
    Table 23. Europe Evolocumab Sales by Country (2017-2022) & (Kg)
    Table 24. Europe Evolocumab Sales Market Share by Country (2017-2022)
    Table 25. Europe Evolocumab Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Evolocumab Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Evolocumab Sales by Region (2017-2022) & (Kg)
    Table 28. Asia Pacific Evolocumab Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Evolocumab Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Evolocumab Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Evolocumab Sales by Country (2017-2022) & (Kg)
    Table 32. Latin America Evolocumab Sales Market Share by Country (2017-2022)
    Table 33. Latin America Evolocumab Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Evolocumab Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Evolocumab Sales by Country (2017-2022) & (Kg)
    Table 36. Middle East and Africa Evolocumab Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Evolocumab Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Evolocumab Revenue Market Share by Country (2017-2022)
    Table 39. Global Evolocumab Sales by Type (2017-2022) & (Kg)
    Table 40. Global Evolocumab Sales Market Share by Type (2017-2022)
    Table 41. Global Evolocumab Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Evolocumab Revenue Share by Type (2017-2022)
    Table 43. Global Evolocumab Price by Type (2017-2022) & (US$/Kg)
    Table 44. Global Evolocumab Sales (Kg) by Application (2017-2022)
    Table 45. Global Evolocumab Sales Market Share by Application (2017-2022)
    Table 46. Global Evolocumab Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Evolocumab Revenue Share by Application (2017-2022)
    Table 48. Global Evolocumab Price by Application (2017-2022) & (US$/Kg)
    Table 49. BOCSCI Corporation Information
    Table 50. BOCSCI Description and Business Overview
    Table 51. BOCSCI Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 52. BOCSCI Evolocumab Product
    Table 53. BOCSCI Recent Developments/Updates
    Table 54. Carbosynth Corporation Information
    Table 55. Carbosynth Description and Business Overview
    Table 56. Carbosynth Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 57. Carbosynth Evolocumab Product
    Table 58. Carbosynth Recent Developments/Updates
    Table 59. TargetMol Chemicals Corporation Information
    Table 60. TargetMol Chemicals Description and Business Overview
    Table 61. TargetMol Chemicals Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 62. TargetMol Chemicals Evolocumab Product
    Table 63. TargetMol Chemicals Recent Developments/Updates
    Table 64. Chemren Bio-Engineering Corporation Information
    Table 65. Chemren Bio-Engineering Description and Business Overview
    Table 66. Chemren Bio-Engineering Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 67. Chemren Bio-Engineering Evolocumab Product
    Table 68. Chemren Bio-Engineering Recent Developments/Updates
    Table 69. DC Chemicals Corporation Information
    Table 70. DC Chemicals Description and Business Overview
    Table 71. DC Chemicals Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 72. DC Chemicals Evolocumab Product
    Table 73. DC Chemicals Recent Developments/Updates
    Table 74. Hefei Enli Medical Technology Corporation Information
    Table 75. Hefei Enli Medical Technology Description and Business Overview
    Table 76. Hefei Enli Medical Technology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 77. Hefei Enli Medical Technology Evolocumab Product
    Table 78. Hefei Enli Medical Technology Recent Developments/Updates
    Table 79. Hefei Hirisun Pharmatech Corporation Information
    Table 80. Hefei Hirisun Pharmatech Description and Business Overview
    Table 81. Hefei Hirisun Pharmatech Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 82. Hefei Hirisun Pharmatech Evolocumab Product
    Table 83. Hefei Hirisun Pharmatech Recent Developments/Updates
    Table 84. Hubei Kele Fine Chemical Corporation Information
    Table 85. Hubei Kele Fine Chemical Description and Business Overview
    Table 86. Hubei Kele Fine Chemical Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 87. Hubei Kele Fine Chemical Evolocumab Product
    Table 88. Hubei Kele Fine Chemical Recent Developments/Updates
    Table 89. Hubei Xingcheng Biotechnology Corporation Information
    Table 90. Hubei Xingcheng Biotechnology Description and Business Overview
    Table 91. Hubei Xingcheng Biotechnology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 92. Hubei Xingcheng Biotechnology Evolocumab Product
    Table 93. Hubei Xingcheng Biotechnology Recent Developments/Updates
    Table 94. Hubei Zhongshan Medical Technology Corporation Information
    Table 95. Hubei Zhongshan Medical Technology Description and Business Overview
    Table 96. Hubei Zhongshan Medical Technology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 97. Hubei Zhongshan Medical Technology Evolocumab Product
    Table 98. Hubei Zhongshan Medical Technology Recent Developments/Updates
    Table 99. Nantong Feiyu Biological Technology Corporation Information
    Table 100. Nantong Feiyu Biological Technology Description and Business Overview
    Table 101. Nantong Feiyu Biological Technology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 102. Nantong Feiyu Biological Technology Evolocumab Product
    Table 103. Nantong Feiyu Biological Technology Recent Developments/Updates
    Table 104. Nantong Hi-Future Biotechnology Corporation Information
    Table 105. Nantong Hi-Future Biotechnology Description and Business Overview
    Table 106. Nantong Hi-Future Biotechnology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 107. Nantong Hi-Future Biotechnology Evolocumab Product
    Table 108. Nantong Hi-Future Biotechnology Recent Developments/Updates
    Table 109. Shanghai Biochempartner Corporation Information
    Table 110. Shanghai Biochempartner Description and Business Overview
    Table 111. Shanghai Biochempartner Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 112. Shanghai Biochempartner Evolocumab Product
    Table 113. Shanghai Biochempartner Recent Developments/Updates
    Table 114. Shanghai Loulan Biotechnology Corporation Information
    Table 115. Shanghai Loulan Biotechnology Description and Business Overview
    Table 116. Shanghai Loulan Biotechnology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 117. Shanghai Loulan Biotechnology Evolocumab Product
    Table 118. Shanghai Loulan Biotechnology Recent Developments/Updates
    Table 119. Shanghai Macklin Biochemical Corporation Information
    Table 120. Shanghai Macklin Biochemical Description and Business Overview
    Table 121. Shanghai Macklin Biochemical Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 122. Shanghai Macklin Biochemical Evolocumab Product
    Table 123. Shanghai Macklin Biochemical Recent Developments/Updates
    Table 124. Shanghai Minkai Biotechnology Corporation Information
    Table 125. Shanghai Minkai Biotechnology Description and Business Overview
    Table 126. Shanghai Minkai Biotechnology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 127. Shanghai Minkai Biotechnology Evolocumab Product
    Table 128. Shanghai Minkai Biotechnology Recent Developments/Updates
    Table 129. Shanghai Ruihui Chemical Technology Corporation Information
    Table 130. Shanghai Ruihui Chemical Technology Description and Business Overview
    Table 131. Shanghai Ruihui Chemical Technology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 132. Shanghai Ruihui Chemical Technology Evolocumab Product
    Table 133. Shanghai Ruihui Chemical Technology Recent Developments/Updates
    Table 134. Shanghai Yifei Biotechnology Corporation Information
    Table 135. Shanghai Yifei Biotechnology Description and Business Overview
    Table 136. Shanghai Yifei Biotechnology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 137. Shanghai Yifei Biotechnology Evolocumab Product
    Table 138. Shanghai Yifei Biotechnology Recent Developments/Updates
    Table 139. Sichuan Weiqi Biotechnology Corporation Information
    Table 140. Sichuan Weiqi Biotechnology Description and Business Overview
    Table 141. Sichuan Weiqi Biotechnology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 142. Sichuan Weiqi Biotechnology Evolocumab Product
    Table 143. Sichuan Weiqi Biotechnology Recent Developments/Updates
    Table 144. Taizhou KEDE Chemical Corporation Information
    Table 145. Taizhou KEDE Chemical Description and Business Overview
    Table 146. Taizhou KEDE Chemical Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 147. Taizhou KEDE Chemical Evolocumab Product
    Table 148. Taizhou KEDE Chemical Recent Developments/Updates
    Table 149. Taizhou Kerui Bio-Technology Corporation Information
    Table 150. Taizhou Kerui Bio-Technology Description and Business Overview
    Table 151. Taizhou Kerui Bio-Technology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 152. Taizhou Kerui Bio-Technology Evolocumab Product
    Table 153. Taizhou Kerui Bio-Technology Recent Developments/Updates
    Table 154. WeiShi Reagent Corporation Information
    Table 155. WeiShi Reagent Description and Business Overview
    Table 156. WeiShi Reagent Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 157. WeiShi Reagent Evolocumab Product
    Table 158. WeiShi Reagent Recent Developments/Updates
    Table 159. Wuhan Fortuna Chemical Corporation Information
    Table 160. Wuhan Fortuna Chemical Description and Business Overview
    Table 161. Wuhan Fortuna Chemical Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 162. Wuhan Fortuna Chemical Evolocumab Product
    Table 163. Wuhan Fortuna Chemical Recent Developments/Updates
    Table 164. Wuhan Sunrise Technology Development Corporation Information
    Table 165. Wuhan Sunrise Technology Development Description and Business Overview
    Table 166. Wuhan Sunrise Technology Development Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 167. Wuhan Sunrise Technology Development Evolocumab Product
    Table 168. Wuhan Sunrise Technology Development Recent Developments/Updates
    Table 169. Wuhan Weisman Bioengineering Corporation Information
    Table 170. Wuhan Weisman Bioengineering Description and Business Overview
    Table 171. Wuhan Weisman Bioengineering Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 172. Wuhan Weisman Bioengineering Evolocumab Product
    Table 173. Wuhan Weisman Bioengineering Recent Developments/Updates
    Table 174. Wuhan Yingnuo Pharmaceutical Technology Corporation Information
    Table 175. Wuhan Yingnuo Pharmaceutical Technology Description and Business Overview
    Table 176. Wuhan Yingnuo Pharmaceutical Technology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 177. Wuhan Yingnuo Pharmaceutical Technology Evolocumab Product
    Table 178. Wuhan Yingnuo Pharmaceutical Technology Recent Developments/Updates
    Table 179. Production Base and Market Concentration Rate of Raw Material
    Table 180. Key Suppliers of Raw Materials
    Table 181. Evolocumab Distributors List
    Table 182. Evolocumab Customers List
    Table 183. Evolocumab Market Trends
    Table 184. Evolocumab Market Drivers
    Table 185. Evolocumab Market Challenges
    Table 186. Evolocumab Market Restraints
    Table 187. Global Evolocumab Sales Forecast by Type (2023-2028) & (Kg)
    Table 188. Global Evolocumab Sales Market Share Forecast by Type (2023-2028)
    Table 189. Global Evolocumab Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 190. Global Evolocumab Revenue Market Share Forecast by Type (2023-2028)
    Table 191. Global Evolocumab Sales Forecast by Application (2023-2028) & (Kg)
    Table 192. Global Evolocumab Sales Market Share Forecast by Application (2023-2028)
    Table 193. Global Evolocumab Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 194. Global Evolocumab Revenue Market Share Forecast by Application (2023-2028)
    Table 195. Global Evolocumab Sales Forecast by Region (2023-2028) & (Kg)
    Table 196. Global Evolocumab Sales Market Share Forecast by Region (2023-2028)
    Table 197. Global Evolocumab Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 198. Global Evolocumab Revenue Market Share Forecast by Region (2023-2028)
    Table 199. Research Programs/Design for This Report
    Table 200. Key Data Information from Secondary Sources
    Table 201. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Evolocumab
    Figure 2. Global Evolocumab Market Share by Type in 2021 & 2028
    Figure 3. Patent Product Picture
    Figure 4. Generic Product Picture
    Figure 5. Global Evolocumab Market Share by Application in 2021 & 2028
    Figure 6. Chemical
    Figure 7. Pharmaceutical
    Figure 8. Global Evolocumab Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 9. Global Evolocumab Market Size (2017-2028) & (US$ Million)
    Figure 10. Global Evolocumab Sales (2017-2028) & (Kg)
    Figure 11. Evolocumab Sales Share by Manufacturers in 2021
    Figure 12. Global Evolocumab Revenue Share by Manufacturers in 2021
    Figure 13. The Global 5 and 10 Largest Evolocumab Players: Market Share by Revenue in 2021
    Figure 14. Evolocumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 15. Global Evolocumab Sales Market Share by Region (2017-2022)
    Figure 16. Global Evolocumab Sales Market Share by Region in 2021
    Figure 17. Global Evolocumab Revenue Market Share by Region (2017-2022)
    Figure 18. Global Evolocumab Revenue Market Share by Region in 2021
    Figure 19. United States Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 20. Canada Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Germany Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. France Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. U.K. Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Italy Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Russia Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. China Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Japan Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. South Korea Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. India Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Australia Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. China Taiwan Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Indonesia Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Thailand Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Malaysia Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Mexico Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Brazil Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Argentina Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Turkey Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Saudi Arabia Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. UAE Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Sales Market Share of Evolocumab by Type (2017-2022)
    Figure 42. Manufacturing Cost Structure of Evolocumab
    Figure 43. Manufacturing Process Analysis of Evolocumab
    Figure 44. Evolocumab Industrial Chain Analysis
    Figure 45. Channels of Distribution
    Figure 46. Distributors Profiles
    Figure 47. Bottom-up and Top-down Approaches for This Report
    Figure 48. Data Triangulation
    Figure 49. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
BOCSCI
Carbosynth
TargetMol Chemicals
Chemren Bio-Engineering
DC Chemicals
Hefei Enli Medical Technology
Hefei Hirisun Pharmatech
Hubei Kele Fine Chemical
Hubei Xingcheng Biotechnology
Hubei Zhongshan Medical Technology
Nantong Feiyu Biological Technology
Nantong Hi-Future Biotechnology
Shanghai Biochempartner
Shanghai Loulan Biotechnology
Shanghai Macklin Biochemical
Shanghai Minkai Biotechnology
Shanghai Ruihui Chemical Technology
Shanghai Yifei Biotechnology
Sichuan Weiqi Biotechnology
Taizhou KEDE Chemical
Taizhou Kerui Bio-Technology
WeiShi Reagent
Wuhan Fortuna Chemical
Wuhan Sunrise Technology Development
Wuhan Weisman Bioengineering
Wuhan Yingnuo Pharmaceutical Technology
Frequently Asked Questions
Evolocumab report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Evolocumab report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Evolocumab report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Matuzumab

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Afutuzumab

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Ofatumumab

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Secukinumab

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More